Skip to main content

Main menu

  • About
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
    • News and Stories
    • Careers
  • Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health
      • Healthy Aging and Mobility
      • Heart Health
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
      • Other Research Focus Areas
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
    • Research Cores
      • Clinical Trials Platform
      • VCH-VCHRI AI Hub
      • Indigenous Health Research Unit
    • Researcher Directory
    • Events and Workshops
    • Participate in Research
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Research Development
      • Awards and Funding
      • Research Facilitation
      • Grant Management
      • Learning and Development
    • Contracts and Compliance
      • Contract Facilitation at VCHRI
      • Operational Approval
      • Research Privacy
      • Clinical Trials Administration
    • Research Support
      • Communications and Media Relations
      • Financial Policies and Procedures
      • VCH-VCHRI AI Hub
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Clinical Trials
    • Clinical Trials Platform
      • Phase 1 Clinical Trials Research Unit
      • Hematology Research Unit
      • Clinical Research Unit
    • Find a Study
    • Researcher Directory
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Research
  3. Participate in Research
  4. Ask an expert: How can I protect my vision if I’m at risk of glaucoma?

Ask an expert: How can I protect my vision if I’m at risk of glaucoma?

Stories Mar 6, 2026 4 minutes

Our expert shares what you need to know about glaucoma and why early detection matters.

Glaucoma is one of the leading causes of vision loss worldwide. Often called the “the silent thief of sight”, it develops gradually and without noticeable symptoms, making it easy to overlook until it becomes more serious. Because vision loss due to glaucoma cannot be reversed, understanding your risk factors and acting early is key to protecting your long-term eye health.

Vancouver Coastal Health Research Institute researcher Dr. Joanne Matsubara explains the science behind early changes in vision and how research is helping glaucoma care shift from reacting to vision loss after it happens to preventing it before it starts. 

Q: What is glaucoma and how does it affect vision?
A:
Glaucoma is a group of disorders that gradually damage the optic nerve, which carries visual information from the eye to the brain. As these nerve fibers are damaged, the signal weakens, and vision slowly fades. High eye pressure is the most common driver of this damage, but some people develop glaucoma even with normal high pressure. This means other factors, such as blood flow and how vulnerable the nerve tissue is, also play a role.

What makes glaucoma especially challenging is how quietly it progresses. The earliest damage affects peripheral vision, which many people do not notice. As a result, the disease may be active for years before symptoms become obvious. 

Q: What early changes in my eyesight might signal glaucoma? 
A:
Glaucoma “hides in plain sight”. Early on, you may not notice any change because the vision you rely on most, your straight-ahead central vision, usually remains intact. Instead, damage first appears in your peripheral vision, which the brain learns to compensate for. 

Over time, you may notice that you are bumping into objects or feel less aware of your surroundings. These changes usually reflect damage that has been building up quietly for years. Some people also experience subtle difficulties with low light or contrast, such as needing more light to see clearly or struggling when moving from bright to dim environment. 

Q: Does glaucoma only happen to older adults? Am I at risk even if I have good eyesight?
A:
Age is one of the strongest risk factors for glaucoma, but it is not the only one. Glaucoma isn’t about how sharp your eyesight is. It is about how resilient the optic nerve is over time, and genetics play a major role in that resilience. 

Large population studies show that having a parent, sibling or close relative with glaucoma significantly increases your risk. It doesn’t mean the disease is inevitable, but it does suggest that some optic nerves are simply more vulnerable based on how they’re built and how they respond to stress.

Q: If I am diagnosed with glaucoma, what can I expect as it progresses? 
A:
Progression refers to how quickly the optic nerve changes over time. For most people, these changes happen slowly over many years. Doctors measure progression by tracking the gradual loss of nerve fibers that carry visual information to the brain. 

This loss first appears as small gaps in peripheral vision that are usually too subtle to notice without specialized imaging and visual field tests. If glaucoma is not detected early and well controlled, these gaps can slowly expand and move toward the center of vision.

Q: Do medications or surgery help preserve vision? Can lifestyle choices help manage the condition?
A:
Glaucoma treatment focuses on slowing the disease rather than reversing it. Research shows that lowering eye pressure is the most effective way to protect the optic nerve, as it reduces stress on the optic nerve and mitigates the loss of nerve fibers. This can be achieved with eye drops, laser treatment or surgery. Large clinical trials show that even modest reductions in eye pressure can meaningfully slow vision loss over time. While treatments cannot restore nerve cells that are already damaged, they can help preserve the vision that remains. 

Lifestyle factors play a smaller but supportive role. Regular exercise, good heart health and stable blood and eye pressure can help strengthen optic nerve health. These steps do not replace medical treatment, but they can help the nerve tolerate long term stress more effectively. 

Q: What new research or technologies are helping detect vision loss earlier or improve long-term outcomes for people living with glaucoma?
A:
There is a lot of exciting glaucoma research underway. Clinicians can now directly measure the optic nerve using high-resolution imaging of the retina rather than relying only on what patients can see during an eye exam. These tools allow doctors to detect nerve damage years earlier than before, often before any vision changes are noticeable, and to track whether the disease is stable or progressing. 

Artificial intelligence is also being used to analyze these scans and visual field tests. These systems can identify subtle patterns that help predict who is likely to worsen more quickly and who may need stronger treatment.

On the treatment side, our research lab is studying ways to protect and potentially regenerate optic nerve cells, as well as “smart” gene therapies that release protective molecules only when the eye is under stress. Together, these advances are shifting glaucoma care from reacting to vision loss to anticipating and preventing it.

Dr. Joanne Matsubara is a professor and the lead principal investigator for the UBC Research Excellence Cluster in Vision Sciences. She is also a member of the Djavad Mowafaghian Centre for Brain Health. Her research focuses on basic and translational research on retinal diseases including age-related macular degeneration, proliferative vitreoretinopathy, proliferative diabetic retinopathy and glaucoma.

Researchers

Joanne Matsubara

Related Articles

The influence of social situations on memory

Specialized AI could elevate diabetes-related blindness risk prevention

Behind the lab doors: Eye Care Centre

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Instagram
  • Email

Related Research Centres/Programs

Djavad Mowafaghian Centre for Brain Health

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Stories

Ask an expert: How can I strike a healthier balance with my daily habits?

Sep 10, 2026 exercise, mobility
Type
Stories

Moving endometrial cancer prevention upstream

Sep 8, 2026 women, cancer, uterine
Type
Stories

Improving respiratory protection for wildland firefighters

Sep 3, 2026 lung, environment, safety
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy